<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03587519</url>
  </required_header>
  <id_info>
    <org_study_id>17-0929</org_study_id>
    <nct_id>NCT03587519</nct_id>
  </id_info>
  <brief_title>Short or Long Interval to Ileostomy Reversal After Ileal Pouch Surgery</brief_title>
  <acronym>SLIRPS</acronym>
  <official_title>Short Versus Long Interval to Loop Ileostomy Reversal After Ileal Pouch Surgery in Patients With Ulcerative Colitis (SLIRPS) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients with ulcerative or indeterminate colitis who undergo ileal pouch anal anastomosis
      and diverting loop ileostomy (IPAA) surgery* a short interval to loop ileostomy reversal will
      result in differences in complications and quality of life compared to a long interval to
      loop ileostomy reversal.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim #1: To compare the Comprehensive Complication Index (CCI), the incidence of postoperative
      complications, including total number of complications per patient, percent of patients with
      complications, and total number of ostomy-related complications per patient among IPAA
      patients who have their ileostomy reversed after a short interval compared to a long
      interval.

      Aim #2: To compare the short vs. long interval groups on measures of health-related quality
      of life (PROMIS) and IPAA functional outcomes
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comprehensive Complication Index at 6 months after randomization.</measure>
    <time_frame>6 months</time_frame>
    <description>The CCI® calculator is an online tool to support the assessment of patients' overall morbidity. The Comprehensive Complication Index (CCI®) is based on the complication grading by Clavien-Dindo Classification and implements every occurred complication after an intervention. The overall morbidity is reflected on a scale from 0 (no complication) to 100 (death).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total number of postoperative complications per patient</measure>
    <time_frame>6 months</time_frame>
    <description>Post-operative complications. For example, surgical site infection, venous thromboembolism, lung or heart-related complications, etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of patients with complications</measure>
    <time_frame>1-2 month intervals after randomization through 6 months&quot;.</time_frame>
    <description>Percentage of patients with one or more postoperative complication such as surgical site infection, venous thromboembolism, lung or heart-related complications, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total number of stoma related complications per patient</measure>
    <time_frame>1-2 month intervals after randomization through 6 months</time_frame>
    <description>Examples: leakage, pain, retraction, prolapse, bleeding, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life</measure>
    <time_frame>Once, at 6 months after ostomy closure surgery</time_frame>
    <description>PROMIS questionnaire. This will be used to assess the study patient's overall health, quality of life, physical health, mental health, social activities, relationships, activities of daily living, emotional health, fatigue level, and pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IPAA functional outcomes</measure>
    <time_frame>Once, at 6 months after ostomy closure surgery</time_frame>
    <description>Daily stools, nightly stools, stool seepage, stool incontinence, anti-peristaltic medication use</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">152</enrollment>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>Early ileostomy closure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Early ileostomy closure will be performed 7 to 12 days after with ileal j-pouch anal anastomosis (IPAA) and loop ileostomy (IPAA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late ileostomy closure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Late ileostomy closure will be performed 8 - 12 weeks after IPAA.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Early</intervention_name>
    <description>Early ileostomy closure</description>
    <arm_group_label>Early ileostomy closure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Late</intervention_name>
    <description>Late ileostomy closure</description>
    <arm_group_label>Late ileostomy closure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consents.

          -  Man or woman between 18 and 64 years of age.

          -  Ulcerative colitis (UC) or indeterminate colitis (IC) diagnosed by routine clinical,
             radiographic, endoscopic, and pathological criteria.

          -  Patient will be scheduled for non-emergent proctocolectomy or completion proctectomy
             with ileal j-pouch anal anastomosis (IPAA) and loop ileostomy (IPAA).

          -  Clinical assessment of patient after IPAA surgery indicates that patient is suitable
             for early ileostomy reversal

        Exclusion Criteria:

          -  Age &lt; 18 or &gt; 64 years

          -  Colon or rectal cancer

          -  Crohn's disease or suspected Crohn's disease

          -  Prednisone dose &gt; 20 mg per day (or equivalent other steroid dose) within 4 weeks of
             scheduled IPAA

          -  Body mass index (BMI) equal to or greater than 40 kg/m2

          -  Hemodynamic instability (persistent pulse rate &lt; 50 or &gt; 120 bpm, systolic blood
             pressure &lt; 90 or &gt; 160 mm Hg, uncontrolled cardiac arrhythmia, or active vasopressor
             drug use)

          -  Organ transplant recipient (e.g. Liver, Kidney, Pancreas)

          -  Immunosuppression due to chemotherapy drug use or systemic disease.

          -  Sepsis

          -  Renal insufficiency (i.e. serum creatinine ? 2 mg/dl or need for dialysis)

          -  Therapeutic anticoagulation (e.g. venous thromboembolic disease, prosthetic heart
             valve)

          -  Blood Hemoglobin &lt; 8 g/dl

          -  Serum Albumin &lt; 2.5 g/dl

          -  Individualized decision by the surgeon to exclude the patient based on sound surgical
             judgment

          -  Pregnant patients and female patients who do not satisfy the standard of care
             requirements of participating centers for an elective surgical procedure.

          -  Clinical assessment of patient after IPAA surgery indicates that patient is not
             suitable for early ileostomy reversal

          -  Participation in another clinical trial within the last 30 days, or simultaneous
             participation in another clinical trial

          -  Well-founded doubt about the patient's cooperation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jon Vogel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92697</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedars Sinai</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <zip>33331</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massuchusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27514</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals of Cleveland</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pennsylvania State University</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor University</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>76798</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>June 26, 2018</study_first_submitted>
  <study_first_submitted_qc>July 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2018</study_first_posted>
  <last_update_submitted>January 16, 2020</last_update_submitted>
  <last_update_submitted_qc>January 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

